Publication | Open Access

Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist

Vivo ProfilesBiochemistryFunctional SelectivityMedicineMechanism Of ActionPharmacological AgentPharmacotherapyNovel ClassPharmacologyDrug DiscoveryDrug Resistance